Johan W. Mouton

International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti‐infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)

Brian T. Tsuji, Jason M. Pogue, Alexandre Prehn Zavascki et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2019 · 869 citations · Full text

Polymyxin Antibiotics Colistin, Susceptibility Testing, Pharmacotherapy +19

Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial

Mical Paul, George L. Daikos, Emanuele Durante‐Mangoni et al. · The Lancet Infectious Diseases · 2018 · 593 citations

Severe Infections, Health Sciences, Antibiotics +9

Nasal Carriage Of Staphylococcus aureus As A Major Risk Factor For Wound Infections After Cardiac Surgery

Jan Kluytmans, Johan W. Mouton, E. P. F. IJzerman et al. · The Journal of Infectious Diseases · 1995 · 431 citations

Adult Cardiac Surgery, Staphylococcus Aureus, Surgery +19

Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus

Roger L. Nation, Jian Li, Otto Cars et al. · The Lancet Infectious Diseases · 2014 · 331 citations

Microbial Toxin, Gastroenterology, Microbiology +8

European Committee on Antimicrobial Susceptibility Testing (EUCAST) Technical Notes on antimicrobial susceptibility testing

Gunnar Kahlmeter, D F Brown, F. W. Goldstein et al. · Clinical Microbiology and Infection · 2006 · 318 citations

Antimicrobial Susceptibility, Antibiotics, Healthcare-associated Infection +8